Controlling serogroup B invasive meningococcal disease: the Canadian perspective

Author： Bettinger Julie A   Deeks Shelley L   Halperin Scott A   Tsang Raymond   Scheifele David W  

Publisher： Informa Healthcare

ISSN： 1476-0584

Source： Expert Review of Vaccines, Vol.12, Iss.5, 2013-05, pp. : 505-517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

T-Cell Epitope Mapping the PorB Protein of Serogroup B Neisseria meningitidis in B10 Congenic Strains of Mice

By delvig A.A.   Rosenqvist E.   Oftung F.   Robinson J.H.  

Clinical Immunology, Vol. 85, Iss. 2, 1997-11 ,pp. : 134-142

Academic Press

Access to resources Recommend Favorite

Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines

By Andersen S.R.   Bjune G.   Lyngby J.   Bryn K.   Jantzen E.  

Microbial Pathogenesis, Vol. 19, Iss. 3, 1995-09 ,pp. : 159-168

Academic Press

Access to resources Recommend Favorite

Bacterial contamination of cellular blood products: the Canadian perspective

By Goldman M.   Sher G.   Blajchman M.  

Transfusion and Apheresis Science, Vol. 23, Iss. 1, 2000-08 ,pp. : 17-19

Elsevier

Access to resources Recommend Favorite

Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay

By Ison C.A.   Anwar N.   Cole M.J.   Galassini R.   Heyderman R.S.   Klein N.J.   West J.   Pollard A.J.   Morley S.   Levin and the Meningococcal Research Group M.  

Microbial Pathogenesis, Vol. 27, Iss. 4, 1999-10 ,pp. : 207-214

Academic Press

Access to resources Recommend Favorite

Novel Immunotherapeutic Strategies for Invasive Fungal Disease

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 209-217

Bentham Science Publishers

Access to resources Recommend Favorite